Like CBD, CBC is non-psychoactive. This lack of ability to produce a “high” sets CBC apart from THC.
In addition, CBC behaves differently within the endocannabinoid system (ECS), or the master regulator of body functions. CBC is capable of interacting with receptors outside of the ECS, which distinguishes it from other cannabinoids.
Through this interaction with various receptors, CBC appears to have an especially strong effect on pain and inflammation, possibly even stronger than dangerously addictive opioids. With further research and testing, CBC could become a valuable tool in the battle against opioid addiction.